







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Yuan and Gambee 275 (52): 40946</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Pierce%20banner&url=http://www.piercenet.com&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/1054134641.gif" ALT="Pierce - The Protein People(tm)"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue52/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F275%2F52%2F40946">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/M007832200v1">doi:10.1074/jbc.M007832200</A> on October 4, 2000</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 275, Issue 52, 40946-40951, December 29, 2000</FONT><BR>
		
	

 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/52/40946">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/52/40946">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/52/40946">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/52/40946&title=Phosphorylation+of+p300+at+Serine+89+by+Protein+Kinase+C">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007832200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=11020388&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=11020388&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Yuan+LW&link_type=AUTHORSEARCH">Yuan, L. W.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Gambee+JE&link_type=AUTHORSEARCH">Gambee, J. E.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/52/40946&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F52%2F40946"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/52/40946">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/52/40946<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007832200v1">M007832200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    Phosphorylation of p300 at Serine 89&nbsp;by Protein Kinase C<A HREF="#FN150"><SUP>*</SUP></A>
    <BR>


</H2>



<STRONG>
<NOWRAP>
L. Wuchao 
Yuan<A HREF="#FN152"><SUP><IMG SRC="/math/12pt/normal/link/Dagger.gif" ALIGN=BASELINE ALT="Dagger" BORDER=0></SUP></A> and<WBR>
Jay E. 
Gambee<SUP>&#167;</SUP>
</NOWRAP>
</STRONG>
<P>
From the Oregon Health Sciences University, Portland, Oregon 97201&nbsp;and the <SUP>&#167;</SUP>&nbsp;Protein Structure Facility, Shriners
Hospital for Children, Portland, Oregon 97201
<P>
Received for publication, August 28,&nbsp;2000, and in revised form, October 3,&nbsp;2000
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>CREB-binding protein (CBP</A>)/p300 plays an
important role in the connection of many different signal transduction
pathways and<SUP> </SUP>the promotion of certain differentiation and proliferation
processes.<SUP> </SUP>This role depends upon the ability of CBP/p300 to serve as
coactivator<SUP> </SUP>for transcription factors. It has been suggested that
CBP/p300<SUP> </SUP>is regulated by phosphorylation, but the nature of the
phosphorylation,<SUP> </SUP>the responsible kinase <I>in vivo</I>, and its
physiological significance<SUP> </SUP>are still unclear. Here, we demonstrate the
first identification<SUP> </SUP>of an <I>in vivo</I> phosphorylation site,
conserved serine 89,&nbsp;in p300.<SUP> </SUP>Signal-dependent protein
kinase C is able to phosphorylate serine<SUP> </SUP>89&nbsp;and mediates this
phosphorylation event <I>in vivo</I>. Different<SUP> </SUP>from other
phosphorylation observed so far in CBP/p300, this serine<SUP> </SUP>89-specific
phosphorylation represses the transcriptional activity<SUP> </SUP>of p300. This
phosphorylation-mediated regulation of p300 function<SUP> </SUP>represents a
previously unrecognized signal transduction pathway<SUP> </SUP>for protein kinase
C to regulate cell growth and<SUP> </SUP>differentiation.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<A NAME="Introduction"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>Adenoviral E1A-binding protein p300 and CREB-binding protein
(CBP</A>)<SUP>1</SUP> are highly conserved
in their primary sequences and closely related<SUP> </SUP>in their functions
(<A HREF="#B1">1-5</A>). Homologues of CBP/p300 have been found<SUP> </SUP>in <I>Drosophila</I>
(<A HREF="#B6">6</A>), <I>Xenopus</I> (<A HREF="#B7">7</A>), and <I>Caenorhabditis elegans</I><SUP> </SUP>(<A HREF="#B8">8</A>).
Many studies have suggested that CBP/p300 is critically<SUP> </SUP>involved in the
control of development, proliferation, differentiation,<SUP> </SUP>and apoptosis
(<A HREF="#B9">9</A>, <A HREF="#B10">10</A>).
</P>
<P>Most studies of CBP/p300 have focused on their functions as
transcriptional coactivator (<A HREF="#B1">1</A>, <A HREF="#B11">11</A>). Consequently, the activities<SUP> </SUP>of
CBP/p300 have been proposed as essential and integral for many<SUP> </SUP>fundamental biological events (<A HREF="#B9">9</A>, <A HREF="#B12">12</A>). Precisely how CBP/p300<SUP> </SUP>activates
transcription remains uncertain, however. CBP/p300 have<SUP> </SUP>been shown to
interact with RNA polymerase II and several other<SUP> </SUP>general transcription
factors required for gene activation (<A HREF="#B11">11</A>,<SUP> </SUP><A HREF="#B13">13-15</A>), suggesting a role as
a transcriptional integrator or adaptor.<SUP> </SUP>CBP/p300 have also been found
to contain histone/factor acetyltransferase<SUP> </SUP>(HAT/FAT) activities
(<A HREF="#B16">16-18</A>). Through the activities of intrinsic<SUP> </SUP>or associated HATs,
CBP/p300 may activate transcription through<SUP> </SUP>acetylating histones or
other transcription factors (<A HREF="#B19">19-23</A>).
</P>
<P>Compared with the extensive analysis of the CBP/p300 transcriptional
and HAT</A> activities, little effort has been devoted to<SUP> </SUP>understanding the
regulation of CBP/p300 function. Binding of<SUP> </SUP>E1A to CBP/p300 inhibits
its HAT</A> and transcriptional activities<SUP> </SUP>(<A HREF="#B4">4</A>, <A HREF="#B5">5</A>, <A HREF="#B24">24</A>, <A HREF="#B25">25</A>), although the
precise mechanism of this<SUP> </SUP>inhibition remains unclear. E1A has been
proposed to interact<SUP> </SUP>directly with the CBP/p300 HAT</A> domains, as well as
to disrupt<SUP> </SUP>the interactions of associated HATs, such as P/CAF (<A HREF="#B26">26</A>).
Interactions<SUP> </SUP>between CBP/p300 and components of the RNA polymerase II
holoenzyme<SUP> </SUP>complex may also be disrupted by E1A (<A HREF="#B14">14</A>); SV40 T antigen is<SUP> </SUP>also able to interact with p300 and repress p300-mediated transcription<SUP> </SUP>activation (<A HREF="#B27">27</A>). It has also been proposed that activation of<SUP> </SUP>the
Ras-MAPK pathway allows pp90<SUP><I>rsk</I></SUP> to associate with CBP</A> and
inhibit cAMP-mediated gene transcription<SUP> </SUP>in a manner similar to E1A
(<A HREF="#B28">28</A>).
</P>
<P>Surprisingly few studies have addressed the role of phosphorylation in
regulating CBP/p300 function. Phosphorylated p300 has<SUP> </SUP>been found in
both quiescent and proliferating cells, and the<SUP> </SUP>level of p300
phosphorylation changes along with cell cycle progression<SUP> </SUP>(<A HREF="#B29">29</A>).
Several recent reports have suggested that CBP/p300 may<SUP> </SUP>be
phosphorylated by various kinases that are important in either<SUP> </SUP>cell
cycle regulation or different signal transduction pathways,<SUP> </SUP>and these
phosphorylation events have been speculated to affect<SUP> </SUP>various CBP/p300
activities (<A HREF="#B12">12</A>, <A HREF="#B30">30-33</A>). However, it is still<SUP> </SUP>unclear for the most part
which kinases are responsible for CBP/p300<SUP> </SUP>phosphorylation <I>in
vivo</I> and where the phosphorylation sites occur.<SUP> </SUP>More importantly,
the functional links between specific phosphorylation<SUP> </SUP>events and
CBP/p300 activities remain largely unknown. Elucidating<SUP> </SUP>the nature of
CBP/p300 phosphorylation is essential for understanding<SUP> </SUP>the regulation
of CBP/p300<SUP> </SUP>function.
</P>
<P>To address these issues, we examined the phosphorylation of p300
<I>in vivo</I>. We first identified a major p300 phosphorylation<SUP> </SUP>site and then determined that protein kinase C (PKC</A>) was responsible<SUP> </SUP>for phosphorylation of this site <I>in vivo</I>. By utilizing a
p300<SUP> </SUP>construct bearing a point mutation at the phosphorylation site,<SUP> </SUP>we
examined the effect of the phosphorylation on p300 function.<SUP> </SUP>Our data
suggest that phosphorylation of p300 represses the transcriptional<SUP> </SUP>activity of<SUP> </SUP>p300.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Phosphorylation Assay--</I>

p300 fragments fused to GST</A> on beads
were incubated for 30&nbsp;min at 30&nbsp;&#176;C in kinase buffer (20&nbsp;m<font size=-1>M</font> Hepes, pH 7.4,&nbsp;10&nbsp;m<font size=-1>M</font> magnesium<SUP> </SUP>acetate, 1&nbsp;m<font size=-1>M</font> dithiothreitol, 100&nbsp;&#181;<font size=-1>M</font> ATP) plus
HeLa nuclear extracts<SUP> </SUP>(10-50 &#181;g) (<A HREF="#B34">34</A>). The beads were washed with
BC400 (20&nbsp;m<font size=-1>M</font> Tris-Cl,<SUP> </SUP>pH 7.9,&nbsp;400&nbsp;m<font size=-1>M</font> KCl, 0.2&nbsp;m<font size=-1>M</font> EDTA) containing 1% Triton X-100. The<SUP> </SUP>proteins were
eluted in Laemmli's buffer and separated on an SDS-polyacrylamide<SUP> </SUP>gel.
PKC</A> kinase assays (<A HREF="#B35">35</A>) were carried out in the kinase buffer<SUP> </SUP>supplemented with 0.5&nbsp;m<font size=-1>M</font> CaCl<SUB>2</SUB>, 100&nbsp;ng/ml
phorbol 12-myristate<SUP> </SUP>13-acetate, 100&nbsp;&#181;g/ml phosphatidylserine,
using the p300 fragment<SUP> </SUP>(amino acids 74-163) fused to GST</A>
(rp300n) on beads as substrate.<SUP> </SUP>Either purified PKC</A> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II (100&nbsp;ng) or
other PKC</A> isotypes immunoprecipitated<SUP> </SUP>from HeLa whole cell lysate or
nuclear extracts (200-500 &#181;g) were<SUP> </SUP>used in the assays (<A HREF="#B36">36</A>).



    

    


<P><I>Protein Digestion--</I>

HeLa nuclear extracts adjusted to 350&nbsp;m<font size=-1>M</font> KCl were immunoprecipitated with anti-p300-specific
monoclonal antibodies (<A HREF="#B29">29</A>)<SUP> </SUP>and digested directly for MS analysis.
Alternatively, proteins<SUP> </SUP>were separated first on an SDS-polyacrylamide
gel, electroblotted<SUP> </SUP>onto a nitrocellulose membrane, and stained with
Ponceau S (Sigma).<SUP> </SUP>The desired bands were excised and minced into
1-2-mm pieces.<SUP> </SUP>Trypsin digestion and cyanogen bromide (CNBr</A>, Aldrich)
cleavage<SUP> </SUP>were carried out as described (<A HREF="#B37">37</A>, <A HREF="#B38">38</A>). CNBr-cleaved peptides<SUP> </SUP>were further digested in 50&nbsp;m<font size=-1>M</font> phosphate buffer (pH 7.8)
with<SUP> </SUP>endoproteinase Glu-C (Sigma) overnight at 37&nbsp;&#176;C.



    

    


<P><I>Manual Edman Degradation--</I>

Manual Edman sequencing of labeled
peptides was carried out precisely as described (<A HREF="#B39">39</A>). Briefly, peptides
were immobilized<SUP> </SUP>covalently on an acrylamide-Sequelon disc (Millipore)
using 10<SUP>&nbsp;</SUP>mg/ml 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide in 0.1&nbsp;<font size=-1>M</font><SUP> </SUP>Mes</A> (pH 5.0). The unbound peptides were removed by
washing the<SUP> </SUP>disc with trifluoroacetic acid and methanol. The discs were
then<SUP> </SUP>transferred into an Eppendorf tube and subjected to Edman<SUP> </SUP>degradation.



    

    


<P><I>Metabolic Labeling--</I>

HeLa cells grown in Dulbecco's modified
Eagle's medium containing 5% fetal calf serum in 10-cm dishes at 80%
confluency were<SUP> </SUP>used for metabolic labeling. Cells were washed with
phosphate-buffered<SUP> </SUP>saline and fed with 3&nbsp;ml of either phosphate-free or
methionine-free<SUP> </SUP>Dulbecco's modified Eagle's medium containing 10%
dialyzed fetal<SUP> </SUP>bovine serum. <SUP>32</SUP>P-labeled orthophosphate or
[<SUP>35</SUP>S]methionine was added to the corresponding dishes (1&nbsp;mCi/dish),<SUP> </SUP>which were then incubated at 37&nbsp;&#176;C for 4&nbsp;h. The
medium was aspirated,<SUP> </SUP>and cells were washed with phosphate-buffered
saline before<SUP> </SUP>harvesting.



    

    


<P><I>Peptide Mapping--</I>

The CNBr-cleaved peptides were dissolved in
pH 1.9&nbsp;buffer containing 88% formic acid, acetic acid, and deionized
H<SUB>2</SUB>O (25:78:897)<SUP> </SUP>and loaded onto a cellulose plate (20&nbsp;&#215;&nbsp;20&nbsp;cm). First-dimension<SUP> </SUP>electrophoresis was carried out at 1&nbsp;kV for 30&nbsp;min in pH 1.9&nbsp;buffer.<SUP> </SUP>Second-dimension chromatography was
developed in buffer containing<SUP> </SUP>1-butanol, pyridine, acetic acid, and
deionized H<SUB>2</SUB>O (15:10:3:12)<SUP> </SUP>for 6-8<SUP> </SUP>h.



    

    


<P><I>LC/ESI/MS/MS</A> Analysis--</I>

The protein digest from
immunoprecipitated p300 was applied to a Targa 0.5&nbsp;&#215;&nbsp;150-mm C18
column (Higgins Analytical) using<SUP> </SUP>a 10&nbsp;&#181;l/min flow rate. Mobile
phases contained 0.1% acetic acid<SUP> </SUP>and peptides were eluted with a
0-32% acetonitrile gradient over<SUP> </SUP>80&nbsp;min followed by a 32-65%
acetonitrile gradient over 10&nbsp;min.<SUP> </SUP>Peptides were analyzed on-line by
electrospray ionization mass<SUP> </SUP>spectrometry (ESIMS) using an LCQ ion trap
mass spectrometer (Finnigan)<SUP> </SUP>to measure both peptide whole masses (MS)
and masses of peptide<SUP> </SUP>fragments produced by collision-induced
dissociation (MS/MS).<SUP> </SUP>Initial experiments detected potential
phosphopeptides whose abundance<SUP> </SUP>was too low to trigger data dependent
MS/MS scans. Therefore,<SUP> </SUP>the instrument was programmed to specifically
select these ions<SUP> </SUP>for MS/MS analysis. Relative collision energy of 40%
was used,<SUP> </SUP>with a maximum ion time of 500&nbsp;ms. A total of 8&nbsp;microscans
was<SUP> </SUP>summed for each MS/MS<SUP> </SUP>spectra.



    

    


<P><I>Immunodetection of Serine 89-phosphorylated p300--</I>

A
phosphoserine 89-specific antiserum was prepared by immunizing rabbits
with a p300-derived oligopeptide containing phosphoserine<SUP> </SUP>89&nbsp;(RSGSpSPNLNMGV). The specificity of the antiserum was examined<SUP> </SUP>using
enzyme-linked immunosorbent assay with phosphorylated and<SUP> </SUP>nonphosphorylated oligopeptides at various concentrations.
Subsequently,<SUP> </SUP>the antiserum was tested by Western analysis using
various amounts<SUP> </SUP>of nonphosphorylated rp300n and rp300n phosphorylated
by HeLa<SUP> </SUP>nuclear extracts. In both the enzyme-linked immunosorbent assay<SUP> </SUP>and Western analyses, the antiserum recognized the serine
89-phosphorylated<SUP> </SUP>protein with a high degree of specificity. The
optimal dilution<SUP> </SUP>of the antiserum was used in Western analysis of
immunoprecipitated<SUP> </SUP>p300 to measure the level of serine 89&nbsp;phosphorylation <I>in vivo</I>.



    

    


<P><I>Transfections and CAT</A> Assays--</I>

HeLa cells at 50% confluency
in 10-cm plates were transfected with LipofectAMINE (16&nbsp;&#181;l, Life
Technologies, Inc.) as described<SUP> </SUP>by the manufacturer. The cells for
transfection with the ER</A> construct<SUP> </SUP>were grown in phenol red-free
Dulbecco's modified Eagle's medium<SUP> </SUP>containing 5% dextran-coated
charcoal-treated fetal calf serum<SUP> </SUP>(<A HREF="#B40">40</A>). Ethanol (as a control) or
estradiol (E2, 10&nbsp;n<font size=-1>M</font>) dissolved<SUP> </SUP>in ethanol was added 1&nbsp;h post-transfection. One or two days after<SUP> </SUP>transfection, the cells were
lysed in 100&nbsp;&#181;l of buffer (<A HREF="#B15">15</A>)<SUP> </SUP>followed by a CAT</A> assay using the
organic phase extraction procedure<SUP> </SUP>(<A HREF="#B11">11</A>). CAT</A> activity was normalized
against cotransfected <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase<SUP> </SUP>activity (<A HREF="#B15">15</A>).



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>p300 Is Phosphorylated at Serine 89&nbsp;in Vitro by HeLa Nuclear
Extracts--</I>

To identify the sites of p300 phosphorylation, we
examined a series of bacterially expressed recombinant fragments
representing<SUP> </SUP>the entire length of p300. Only the N-terminal 243-amino
acid<SUP> </SUP>fragment (rp300N) was phosphorylated after incubation with
HeLa<SUP> </SUP>nuclear extracts (Fig.
<a href="#F1">1</a><I>A</I>). This region contains many
potential<SUP> </SUP>phosphorylation sites. To identify these sites, we first
digested<SUP> </SUP>the phosphorylated rp300N protein with trypsin. Tryptic
peptides<SUP> </SUP>were separated by HPLC</A> using a reverse phase C18 column
(VYDAC,<SUP> </SUP>218TP52) (Fig. <a href="#F1">1</a><I>B</I>), and each fraction was monitored
by Cerenkov<SUP> </SUP>counting in a scintillation counter. Two major radiolabeled
fractions<SUP> </SUP>(<I>peaks A</I> and <I>B</I> at retention times of 61&nbsp;and 70&nbsp;min, respectively)<SUP> </SUP>were detected, and these were
subjected to automated Edman sequencing.<SUP> </SUP>Both fractions contained
peptides with N-terminal residues corresponding<SUP> </SUP>to position 87&nbsp;in p300.
The two radiolabeled fractions were further<SUP> </SUP>digested with CNBr</A>,
separated by HPLC</A>, and again subjected to<SUP> </SUP>automated sequencing. Residue
87&nbsp;was again identified as the N<SUP> </SUP>terminus of the radiolabeled peptide.
The labeled peptide <SUP>87</SUP>SGSSPNLNh<SUP>95</SUP> (where h is
either homoserine or homoserine lactone derived from<SUP> </SUP>methionine by CNBr</A>
cleavage) contains serines at positions 87,<SUP>&nbsp;</SUP>89,&nbsp;and 90.&nbsp;Manual Edman
degradation (<A HREF="#B39">39</A>) was used to further<SUP> </SUP>characterize the radiolabeled
tryptic peptide collected from <I>peak<SUP> </SUP>A</I>. At each cycle, both
the eluted solution and the filter bearing<SUP> </SUP>the remaining peptide were
subjected to Cerenkov counting. Only<SUP> </SUP>serine 89&nbsp;at cycle 3&nbsp;was labeled
(Fig. <a href="#F1">1</a><I>C</I>), indicating the site<SUP> </SUP>of phosphorylation. Mutating
residue 89&nbsp;from serine to alanine<SUP> </SUP>in the recombinant p300 N-terminal
construct (rp300NS89A) markedly<SUP> </SUP>decreased the level of phosphorylation
(Fig. <a href="#F1">1</a><I>D</I>) and completely<SUP> </SUP>eliminated labeling of the CNBr</A>
peptide as measured by two-dimensional<SUP> </SUP>peptide mapping (Fig.
<a href="#F1">1</a><I>E</I>). These observations suggest that serine<SUP> </SUP>89&nbsp;is a major
phosphorylation site of the rp300N fragment of p300<SUP> </SUP><I>in
vitro</I>.



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/52/40946/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=148 HEIGHT=200 SRC="/content/vol275/issue52/images/small/bc0119591001.gif"></A><BR>

<STRONG>View larger version</STRONG> (54K):
<BR><NOBR><A HREF="/cgi/content/full/275/52/40946/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/52/40946/F1"
onClick="startTarget('F1', 475, 640); this.href='/cgi/content-nw/full/275/52/40946/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Serine 89&nbsp;is a major phosphorylation site in
p300.</B> <I>A</I>, phosphorylation of rp300N (GST-p300, amino
acids 1-243) by HeLa nuclear extracts (<I>right</I>).
Coomassie-stained input proteins (<I>left</I>). <I>B</I>, HPLC</A>
chromatogram of tryptic fragments of <SUP>32</SUP>P-labeled rp300N;
<I>peaks A</I> and <I>B</I> fractions contained 60% of the
radioactive label. <I>C</I>, manual sequencing of peptides in
<I>peak A.&nbsp;D</I>, phosphorylation of rp300N
(<I>WT</I>) and the point mutant (<I>S89A</I>)
(<I>right</I>). Coomassie-stained input proteins (<I>left</I>).
<I>E</I>, two-dimensional mapping of CNBr</A> fragments of recombinant
rp300N and endogenous p300 proteins. <I>o</I>, origin of sample
application;&nbsp;+&nbsp;and <IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">, polarity of the first-dimension electrophoresis;
<I>arrow</I> indicates direction of second-dimension
chromatography; <I>triangle</I> designates the position of the
phosphoserine 89-containing peptide.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->







    

    


<P><I>Serine 89&nbsp;Is Also Phosphorylated in Endogenous p300--</I>

To
determine whether serine 89&nbsp;is phosphorylated <I>in vivo</I>, we
metabolically labeled the endogenous p300 protein by growing<SUP> </SUP>HeLa cells
in <SUP>32</SUP>P. Two-dimensional peptide mapping of the labeled p300
after digestion<SUP> </SUP>with CNBr</A> revealed a labeled phosphopeptide that
migrated at the<SUP> </SUP>same position as the radiolabeled peptide from rp300N
(Fig. <a href="#F1">1</a><I>E</I>).<SUP> </SUP>Thus, we presume that serine 89&nbsp;is also
phosphorylated in endogenous<SUP> </SUP>p300. To test this hypothesis further, we
used mass spectrometry<SUP> </SUP>to identify the phosphorylation site in the
endogenous p300. p300<SUP> </SUP>immunoprecipitated from nuclear extracts was
digested with CNBr</A><SUP> </SUP>and endoproteinase Glu-C. The digested peptides were
subjected<SUP> </SUP>to online capillary liquid chromatography electrospray tandem<SUP> </SUP>mass spectrometry (LC/ESI/MS/MS</A>). During ionization, the peptide<SUP> </SUP>bearing serine 89&nbsp;(84LLRSGSSPNLNh95) could be either singly or<SUP> </SUP>doubly
charged. The calculated ratios of mass to charge
(<I>m</I>/<I>z</I>)<SUP> </SUP>are 1240.7&nbsp;and 620.8&nbsp;for the
unphosphorylated species, and 1320.7<SUP>&nbsp;</SUP>and 660.8&nbsp;for the species
phosphorylated at one residue. Ions<SUP> </SUP>with either the expected
<I>m</I>/<I>z</I> value for the unphosphorylated or<SUP> </SUP>phosphorylated peptides eluted at 37.9&nbsp;and 41.8&nbsp;min, respectively<SUP> </SUP>(Fig.
<a href="#F2">2</a><I>A</I>). The
<I>m</I>/<I>z</I> values 1240.9&nbsp;and 620.9&nbsp;measured in the MS<SUP> </SUP>spectra were assigned to the unphosphorylated peptide, and the<SUP> </SUP>values
1320.8&nbsp;and 660.7&nbsp;were assigned to the phosphorylated peptide.<SUP> </SUP>These
peptide ions were further isolated and subjected to collision-induced<SUP> </SUP>dissociation to produce MS/MS spectra. This caused fragmentation<SUP> </SUP>of the
parent ions along peptide bonds to produce both <I>y</I> fragment<SUP> </SUP>ions (loss of successive residues from the N terminus) and <I>b</I>
fragment<SUP> </SUP>ions (loss of successive residues from the C terminus). The
identity<SUP> </SUP>of the unphosphorylated peptide was confirmed by the presence<SUP> </SUP>of 15&nbsp;of 22&nbsp;possible <I>b</I> and <I>y</I> series ions in the
MS/MS spectra.<SUP> </SUP>The MS/MS spectra for the phosphorylated parent ions
determined<SUP> </SUP>the identity of the phosphopeptide and the phosphorylation
site<SUP> </SUP>at serine 89.&nbsp;Fig. <a href="#F2">2</a><I>B</I> shows a MS/MS spectrum for the
doubly charged<SUP> </SUP>phosphopeptide ion. The dominant peak with an
<I>m</I>/<I>z</I> value of 611.9<SUP>&nbsp;</SUP>in the spectrum is consistent
with the loss of one phosphate from<SUP> </SUP>the parent ion. Sixteen
<I>b</I> ions and 11&nbsp;<I>y</I> ions were also assigned.<SUP> </SUP>Six of
these <I>b</I> ions and two of these <I>y</I> ions resulted
from the<SUP> </SUP>additional loss of phosphate (<I>b<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta "></I> and
<I>y<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta "></I>). Based on the <I>m</I>/<I>z</I> values,<SUP> </SUP>none
of the <I>b2-b5</I> and <I>y2-y6</I>, which contained serine
87&nbsp;and 90,<SUP>&nbsp;</SUP>respectively, but not serine 89,&nbsp;were phosphorylated. On the
other<SUP> </SUP>hand, the <I>b6-b11</I> and <I>y7-y10</I>, which
contained serine 89,&nbsp;were phosphorylated<SUP> </SUP>and were able to lose
phosphoric acid. This sequence information<SUP> </SUP>obtained from the MS/MS
spectrum provides unambiguous evidence<SUP> </SUP>that serine 89&nbsp;is an <I>in
vivo</I> site of p300 phosphorylation.



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/52/40946/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=153 HEIGHT=200 SRC="/content/vol275/issue52/images/small/bc0119591002.gif"></A><BR>

<STRONG>View larger version</STRONG> (32K):
<BR><NOBR><A HREF="/cgi/content/full/275/52/40946/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/52/40946/F2"
onClick="startTarget('F2', 486, 640); this.href='/cgi/content-nw/full/275/52/40946/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>Phosphoserine 89&nbsp;in endogenous p300 as
determined by </B><B>LC/ESI/MS/MS</B></A><B> analysis.</B> p300 was immunoprecipitated
from HeLa cells, digested with CNBr</A> and then with Glu-C before
analysis by LC/ESI/MS/MS</A>. <I>A</I>, chromatogram displaying
currents for ions with calculated <I>m</I>/<I>z</I> at 620.8&nbsp;(nonphosphorylated) and 660.8&nbsp;(phosphorylated) for the doubly charged
ion <SUP>84</SUP>LLRSGSSPNLNh<SUP>95</SUP>. <I>B</I>, MS/MS
spectrum of the phosphorylated ion with <I>m</I>/<I>z</I> at
660.7.&nbsp;<IMG SRC="/math/12pt/normal/utri.gif" ALIGN=BASELINE ALT="triangle ">, denotes loss of phosphate from the fragment ions. The
recovered <I>b</I> and <I>y</I> fragment ions are listed
<I>above</I> and <I>below</I> the sequence,
respectively. The <I>underline</I> in the sequence indicates
the phosphorylated residue.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->




<P>
To detect serine 89-phosphorylated endogenous p300 easily, we made a
phosphoserine 89-specific antiserum. The specificity<SUP> </SUP>of the antiserum
was examined by enzyme-linked immunosorbent assay<SUP> </SUP>using phosphorylated
and nonphosphorylated oligopeptides (data<SUP> </SUP>not shown) and then by
Western analysis using various amounts<SUP> </SUP>of nonphosphorylated and
phosphorylated recombinant p300 fragment<SUP> </SUP>rp300n (amino acids 74-163),
which contains serine 89&nbsp;(Fig.
<a href="#F3">3</a><I>A</I>).<SUP> </SUP>In both cases, the
antiserum recognized the serine 89-phosphorylated<SUP> </SUP>protein with a high
degree of specificity. In addition, serine<SUP> </SUP>89&nbsp;phosphorylation of p300
could be detected by the antiserum<SUP> </SUP>when a Flag-tagged p300 was
transfected and expressed in HeLa<SUP> </SUP>cells but not when a Flag-tagged p300
bearing a point mutation<SUP> </SUP>at serine 89&nbsp;to alanine was expressed (Fig.
<a href="#F3">3</a><I>B</I>). We subsequently<SUP> </SUP>used the antiserum to detect endogenous
p300 phosphorylated at<SUP> </SUP>serine 89&nbsp;in different cell lines (Fig.
<a href="#F3">3</a><I>C</I>). The serine 89-specific<SUP> </SUP>phosphorylation of p300 in these
cells suggests that this phosphorylation<SUP> </SUP>is a common phenomenon.



<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/52/40946/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=136 HEIGHT=200 SRC="/content/vol275/issue52/images/small/bc0119591003.gif"></A><BR>

<STRONG>View larger version</STRONG> (37K):
<BR><NOBR><A HREF="/cgi/content/full/275/52/40946/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/52/40946/F3"
onClick="startTarget('F3', 450, 640); this.href='/cgi/content-nw/full/275/52/40946/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>p300 is phosphorylated at serine 89&nbsp;<I>in
vivo</I>.</B> <I>A</I>, Western analysis using an antiserum
generated against a phosphoserine 89-containing peptide antigen.
<I>B</I>, the Flag-tagged p300 (<I>Fp300</I>) and point mutant
(serine 89&nbsp;to alanine, <I>Fp300S89A</I>) were transfected and
expressed in HeLa cells, immunoprecipitated with anti-Flag antibodies
from whole cell lysates, and analyzed by Western blot using
anti-p300 and phosphoserine 89-specific antiserum. <I>C</I>, the
p300 protein was immunoprecipitated from whole cell lysates prepared
from different cell lines and analyzed by Western blot using the
phosphoserine 89-specific antiserum.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->







    

    


<P><I>PKC</A> Mediates the Phosphorylation of p300 at Serine 89--</I>

Each of
the N-terminal sequences of human and mouse p300 and CBP</A> contains a
consensus (R<I>XX</I>S) phosphorylation site similar<SUP> </SUP>to that
used by PKC</A> (<A HREF="#B45">45</A>, <A HREF="#B46">46</A>) (Table <a href="#TI">I</a>). This
observation<SUP> </SUP>prompted us to test whether PKC</A> was able to phosphorylate
rp300n.<SUP> </SUP>Purified PKC</A> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II, a classical PKC</A> isotype, phosphorylated
rp300n<SUP> </SUP>but not its serine 89&nbsp;to alanine point mutant (rp300nS89A) (Fig.<SUP> </SUP><a href="#F4">4</a><I>A</I>). In contrast, PKA
(cAMP-dependent kinase) and CaM kinase IV<SUP> </SUP>(calcium/calmodulin-dependent kinase), which also recognize
R<I>XX</I>S<SUP> </SUP>phosphorylation sites (<A HREF="#B45">45</A>) failed to phosphorylate
serine 89<SUP>&nbsp;</SUP>of p300 (data not shown). However, PKC</A> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II was not detected
in<SUP> </SUP>HeLa nuclear extracts (Fig. <a href="#F4">4</a><I>B</I>), and therefore it was not
the<SUP> </SUP>kinase we were looking for. By Western analysis, we found that<SUP> </SUP>several isotypes of PKC</A> exist in HeLa nuclei. Of them, only a<SUP> </SUP>classical
type <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">&nbsp;and a novel type <IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta ">&nbsp;were shown to exist in both<SUP> </SUP>HeLa nuclei
and phosphorylate serine 89&nbsp;in rp300n specifically<SUP> </SUP>(Fig. <a href="#F4">4</a>,
<I>A</I> and <I>B</I>).

<P><CENTER>
<TABLE BORDER WIDTH="95%" CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1><TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF><NOBR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</NOBR><BR><NOBR><STRONG>View this table:</STRONG></NOBR>
<BR><NOBR><A HREF="/cgi/content/full/275/52/40946/TI">[in this window]</A></NOBR><BR>
<NOBR><A HREF="/cgi/content-nw/full/275/52/40946/TI"
	onClick="startTarget('TI', 500, 400); this.href='/cgi/content-nw/full/275/52/40946/TI'"
	onMouseOver="window.status='View table in a separate window';
		return true"
TARGET='TI'>[in a new window]</A><BR>&nbsp;</NOBR>
</TD>
<TD ALIGN=LEFT VALIGN=TOP>
<A NAME="TI"><!-- TABLE I --></A>
<CENTER>
<B>Table I</B><BR>
<STRONG>

    Alignment of human and mouse CBP/p300 N-terminal sequences
<BR>
</STRONG>
</CENTER>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>






<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/52/40946/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=134 HEIGHT=200 SRC="/content/vol275/issue52/images/small/bc0119591004.gif"></A><BR>

<STRONG>View larger version</STRONG> (29K):
<BR><NOBR><A HREF="/cgi/content/full/275/52/40946/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/52/40946/F4"
onClick="startTarget('F4', 444, 640); this.href='/cgi/content-nw/full/275/52/40946/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>Protein kinase C mediates phosphorylation of
p300 at serine 89.</B>&nbsp;<I>A</I>, phosphorylation of wild type
(<I>WT</I>) or point mutant (<I>S89A</I>) rp300n (GST-p300
amino acids 74-163) by purified PKC</A> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II and other PKC</A> isotypes
immunoprecipitated from HeLa cells. <I>B</I>, Western analysis of
the PKC</A> proteins in whole cell lysate (<I>CL</I>) and nuclear
extracts (<I>NE</I>), each prepared from an approximately equal
number of cells. <I>C</I>, Western analysis of p300 phosphorylated
at serine 89&nbsp;after immunoprecipitated with anti-p300 antibodies from
HeLa and U2OS cells treated with calphostin C.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->




<P>
To test whether PKC</A> mediates phosphorylation of p300 at serine 89&nbsp;<I>in vivo</I>, we treated HeLa and U2OS cells with calphostin<SUP> </SUP>C
(<A HREF="#B47">47</A>). Calphostin C inhibits PKC</A> specifically by interacting<SUP> </SUP>with its
regulatory C1 domain (<A HREF="#B48">48</A>), which is common in all PKC</A><SUP> </SUP>isotypes and
binds to its key activator, diacylglycerol (<A HREF="#B49">49</A>).<SUP> </SUP>Levels of serine
89-phosphorylated p300 were measured using the<SUP> </SUP>phosphoserine
89-specific antiserum. The level of the serine 89-phosphorylated<SUP> </SUP>p300
was reduced markedly in calphostin C-treated cells, whereas<SUP> </SUP>the level
of total p300 protein did not change (Fig. <a href="#F4">4</a><I>C</I>). Thus,<SUP> </SUP>we
suggest that PKC</A> mediates phosphorylation of p300 at serine<SUP> </SUP>89&nbsp;in different<SUP> </SUP>cells.



    

    


<P><I>Phosphorylation of p300 at Serine 89&nbsp;Represses Its Function as a
Transcriptional Coactivator--</I>

We next investigated whether
phosphorylation at serine 89&nbsp;affected p300 function. Expression
constructs containing a Gal4<SUP> </SUP>DNA-binding domain fused to either wild
type human p300 (Galp300)<SUP> </SUP>or a cDNA containing a point mutation at
serine 89&nbsp;to alanine<SUP> </SUP>(Galp300S89A) were used in this study. When
transfected into HeLa<SUP> </SUP>cells, the wild type and point mutant fusion
proteins were expressed<SUP> </SUP>at the same level (Fig.
<a href="#F5">5</a><I>A</I>). The point mutant was
significantly<SUP> </SUP>more active than the wild type p300, however, when tested
using<SUP> </SUP>a CAT</A> reporter driven by Gal4 binding sites (Fig. <a href="#F5">5</a><I>B</I>).
These observations<SUP> </SUP>suggest that phosphorylation at serine 89&nbsp;repress
the transcriptional<SUP> </SUP>ability of p300. We further tested whether the p300
point mutation<SUP> </SUP>affected transcription of specific promoters. For these
studies,<SUP> </SUP>we utilized promoters containing an ER-binding site or
activator<SUP> </SUP>protein-1 (AP-1</A>) site derived from the collagenase gene (<A HREF="#B40">40</A>,<SUP> </SUP><A HREF="#B50">50</A>). The serine 89&nbsp;to alanine point mutant was also more active<SUP> </SUP>than
the wild type p300 in potentiating both promoters (Fig. <a href="#F5">5</a>,<SUP> </SUP><I>C</I>
and <I>D</I>). These observations indicate that phosphorylation of<SUP> </SUP>p300 at serine 89&nbsp;represses its ability as a transcriptional
coactivator<SUP> </SUP>and thus suppresses the ER</A> and AP-1</A> activities.



<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/52/40946/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=155 HEIGHT=200 SRC="/content/vol275/issue52/images/small/bc0119591005.gif"></A><BR>

<STRONG>View larger version</STRONG> (27K):
<BR><NOBR><A HREF="/cgi/content/full/275/52/40946/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/52/40946/F5"
onClick="startTarget('F5', 491, 640); this.href='/cgi/content-nw/full/275/52/40946/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B>p300 transcriptional activity is inhibited by
phosphorylation at serine 89.</B>&nbsp;<I>A</I>, cells were labeled
with [<SUP>35</SUP>S]methionine after transfection with Gal4 1-147
(<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">), Galp300 (<I>WT</I>), or Galp300S89A (<I>S89A</I>).
Proteins were immunoprecipitated with anti-Gal4 antibodies.
<I>B-D</I>, transfection with either Gal4 1-147 (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">), Galp300
(<I>WT</I>), or Galp300S89A (<I>S89A</I>) (0.5&nbsp;&#181;g) and
different reporters (1&nbsp;&#181;g each): a Gal4 reporter pG5e1bCAT
(<I>B</I>), pERE-TATA-CAT with ER</A> construct pHEO (0.4&nbsp;&#181;g) in the
presence or absence of estradiol (<I>E2</I>, 10&nbsp;n<font size=-1>M</font>)
(<I>C</I>), and the collagenase reporter pCoII (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">517/+63)-CAT
(pCoII-CAT) or pCoII (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">517/+63 <IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">TRE or AP-1</A>)-CAT (<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">TRE)
(<I>D</I>). CAT</A> activities were normalized to cotransfected
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-galactosidase activity. <I>Error bars</I> represent the
standard deviation (<I>n</I>&nbsp;=&nbsp;3-5). ERE, ER-binding
site.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->







    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Phosphorylation is known to be an important mode of transcription
factor regulation. Components of the basal transcriptional<SUP> </SUP>machinery
and elements of chromatin are also regulated by phosphorylation.<SUP> </SUP>Surprisingly, despite the essential roles of CBP/p300 in
transcriptional<SUP> </SUP>signaling, characterization of their regulation by
phosphorylation<SUP> </SUP>remains relatively unexplored. Several studies have
suggested<SUP> </SUP>that CBP</A> and p300 are phosphorylated (<A HREF="#B12">12</A>, <A HREF="#B30">30-33</A>), but in
most<SUP> </SUP>of these cases, it remains unclear which kinases are responsible<SUP> </SUP>for CBP/p300 phosphorylation <I>in vivo</I> and which specific
residues<SUP> </SUP>are phosphorylated. Here, we present the first identification<SUP> </SUP>of an <I>in vivo</I> phosphorylation site in CBP/p300, characterize
the<SUP> </SUP>responsible kinase, and demonstrate the repression of p300 function<SUP> </SUP>by this phosphorylation. These observations indicate that p300<SUP> </SUP>and
presumably CBP</A> are indeed regulated by phosphorylation. Serine<SUP> </SUP>89&nbsp;of
p300 and its surrounding PKC</A> consensus sequence (R<I>XX</I>S) are<SUP> </SUP>conserved among human and mouse p300 and CBP</A>. Similar to p300,<SUP> </SUP>an
N-terminal fragment of CBP</A> (amino acids 1-270) containing the<SUP> </SUP>corresponding serine was phosphorylated by
PKC</A>.<A HREF="#FN2"><SUP>2</SUP></A> This highly conserved
phosphorylation, plus its inhibitory role<SUP> </SUP>in the regulation of p300
function, implies its importance in<SUP> </SUP>cellular<SUP> </SUP>control.
    
    </P>

    
    <P>p300 was identified originally through its ability to interact with the
adenoviral E1A oncoprotein. To achieve a full level<SUP> </SUP>of cellular
transformation, E1A must bind to both Rb</A> and p300,<SUP> </SUP>which implies
important regulatory roles for both of these cellular<SUP> </SUP>factors in cell
growth (<A HREF="#B3">3</A>, <A HREF="#B51">51</A>). Rb</A> is well known as a tumor<SUP> </SUP>suppressor and a
G<SUB>1</SUB> checkpoint regulator. Inactivation of Rb</A> via<SUP> </SUP>phosphorylation by G<SUB>1</SUB> cyclin-dependent kinases
is crucial to cell<SUP> </SUP>cycle progression. Recent studies show that CBP</A> and
p300 are also<SUP> </SUP>tumor suppressors (<A HREF="#B1">1</A>, <A HREF="#B52">52</A>, <A HREF="#B53">53</A>). The requirement for
CBP/p300<SUP> </SUP>in cell proliferation has been shown in studies using
p300-deficient<SUP> </SUP>mice (<A HREF="#B54">54</A>) and after ribozyme ablation of CBP/p300 in
tissue<SUP> </SUP>culture (<A HREF="#B55">55</A>). Both studies suggest that the level of CBP/p300<SUP> </SUP>is
critical to its role in the regulation of proliferation. Little<SUP> </SUP>is
known about how CBP/p300 subserves this function, however,<SUP> </SUP>or whether
the growth/tumor suppressor actions of CBP/p300 are<SUP> </SUP>similarly regulated
by phosphorylation. Our observations that<SUP> </SUP>phosphorylation at serine 89&nbsp;by PKC</A> represses p300 function suggest<SUP> </SUP>a mechanism by which p300 could
down-regulate cell growth. Conceivably,<SUP> </SUP>the loss of the serine
89-phosphorylation sites in the fusions<SUP> </SUP>of MOZ and MLL to CBP</A> or
p300 could contribute to the mechanisms<SUP> </SUP>that link these translocations
to the development of hematological<SUP> </SUP>malignancies (<A HREF="#B10">10</A>).
    
    </P>

    
    <P>The PKC</A> family of proteins are signal-activated kinases of importance
in major cellular functions. Release of diacylglycerol<SUP> </SUP>and calcium
stimulate PKC</A> activity within a short period of time,<SUP> </SUP>whereas
tumor-promoting phorbol esters (phorbol 12-myristate 13-acetate)<SUP> </SUP>may
regulate PKC</A> activity within a relative long term (<A HREF="#B56">56</A>).<SUP> </SUP>The PKC</A>
isotypes play distinct roles in the regulation of growth<SUP> </SUP>and
differentiation depending on which cell types are being examined<SUP> </SUP>(<A HREF="#B57">57</A>).
Our studies show that PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta "> have the ability to<SUP> </SUP>phosphorylate p300 at serine 89&nbsp;and repress its function in HeLa<SUP> </SUP>cells.
This regulation thus represents a previously unsuspected<SUP> </SUP>signal
transduction pathway for PKC</A> to participate in cellular<SUP> </SUP>controls.
Consistent with this hypothesis, p300 is expected to<SUP> </SUP>participate in
certain differentiation pathways (<A HREF="#B4">4</A>) and overexpression<SUP> </SUP>of PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and
PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta "> upon phorbol ester stimulation-induced differentiation<SUP> </SUP>in a
mouse myeloid progenitor cell line (<A HREF="#B58">58</A>). This induction<SUP> </SUP>of
differentiation by PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta "> may be mediated in part by<SUP> </SUP>phosphorylation of p300. In addition, CBP/p300 as well as PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>and
PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta "> express universally in many different tissues (<A HREF="#B51">51</A>,<SUP> </SUP><A HREF="#B56">56</A>),
indicating a possible global event of phosphorylation of<SUP> </SUP>p300 at serine
89&nbsp;by PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta ">. Indeed, we detected phosphorylation<SUP> </SUP>of p300 at
serine 89&nbsp;in all of the cell lines<SUP> </SUP>examined.
    
    </P>

    
    <P>Previous studies showed that the C-terminal fragments of CBP</A> could be
phosporylated <I>in vitro</I> by cyclin E-Cdk2 kinase (<A HREF="#B32">32</A>).<SUP> </SUP>This
phosphorylation caused an increase in the HAT</A> activity of<SUP> </SUP>CBP</A>. This
observation, combined with our study here, suggests<SUP> </SUP>that there are two
types of regulation by phosphorylation in CBP/p300:<SUP> </SUP>a positive effect
by phosphorylation, causing a short term stimulation<SUP> </SUP>of function, and a
repressive effect by phosphorylation at serine<SUP> </SUP>89,&nbsp;possibly serving a
checkpoint to CBP/p300<SUP> </SUP>function.
    
    </P>

    
    <P>In summary, our findings suggest that p300 is phosphorylated at serine
89&nbsp;by PKC</A> and that this phosphorylation represses its<SUP> </SUP>function. It will
be particularly interesting to investigate whether<SUP> </SUP>this phosphorylation
and repression event of p300 is regulated<SUP> </SUP>in the cell cycle and how
this event contributes to specific cellular<SUP> </SUP>decisions, such as
withdrawal from the cell cycle and<SUP> </SUP>differentiation.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENTS</FONT></TH>
</TR>
</TABLE>


<P>We acknowledge assistance from P.&nbsp;W. Howard
in two-dimensional mapping, from L.&nbsp;L. David in MS analysis, from
R.&nbsp;H. Goodman<SUP> </SUP>in making the phosphoserine 89-specific antiserum, and
from F.<SUP>&nbsp;</SUP>Caldwell during manuscript preparation. We thank P.&nbsp;Chambon for<SUP> </SUP>pHEO and pERE-TATA-CAT plasmids, Yang Shi for pCoII-CAT and <IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">TRE<SUP> </SUP>constructs, A.&nbsp;Newton for PKC<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">II protein, and M.&nbsp;L. Dell'Acqua<SUP> </SUP>and
A.&nbsp;Edwards for anti-PKC antibodies and helpful<SUP> </SUP>discussions.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore<SUP> </SUP>be hereby marked
"<I>advertisement</I>" in
accordance with 18&nbsp;U.S.C.<SUP> </SUP>Section
1734&nbsp;solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN152"><SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP></A>
Supported by a Molecular Hematology training grant from
NRSA, National Institutes of Health, Oregon Cancer Center (to L.&nbsp;W.<SUP>&nbsp;</SUP>Y.). To whom correspondence should be addressed. E-mail:
yuanlw@uswest.net.

<P>


<P>
Published, JBC Papers in Press, October 4,&nbsp;2000,&nbsp;DOI 10.1074/jbc.M007832200

<P>
<P><A NAME="FN2"><SUP>2</SUP></A>
L. W.&nbsp;Yuan, unpublished<SUP> </SUP>data.

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

CBP, CREB
(cAMP response element-binding protein)-binding protein;

HAT, histone
acetyltransferase;

PKC, protein kinase C;

GST, glutathione
<I>S</I>-transferase;

CAT, chloramphenicol acetyltransferase;

ER, estrogen receptor;

HPLC, high pressure liquid chromatography;

LC/ESI/MS/MS, liquid chromatography electrospray ionization tandem mass
spectrometry;

CNBr, cyanogen bromide;

AP-1, activator protein-1;

Rb, retinoblastoma;

<I>m</I>/<I>z</I>, ratio of mass to charge;

Mes, 4-morpholineethanesulfonic acid.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Eckner, R.,
Ewen, M. E.,
Newsome, D.,
Gerdes, M.,
DeCaprio, J. A.,
Lawrence, J. B.,
 and Livingston, D. M.



(1994)

<I>Genes Dev.</I>
<B>8</B>,
869-884<!-- HIGHWIRE ID="275:52:40946:1" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=8/8/869">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Chrivia, J. C.,
Kwok, R. P.,
Lamb, N.,
Hagiwara, M.,
Montminy, M. R.,
 and Goodman, R. H.



(1993)

<I>Nature</I>
<B>365</B>,
855-859<!-- HIGHWIRE ID="275:52:40946:2" --><A HREF="/cgi/external_ref?access_num=8413673&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8413673&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Arany, Z.,
Sellers, W. R.,
Livingston, D. M.,
 and Eckner, R.



(1994)

<I>Cell</I>
<B>77</B>,
799-800<!-- HIGHWIRE ID="275:52:40946:3" --><A HREF="/cgi/external_ref?access_num=8004670&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8004670&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Arany, Z.,
Newsome, D.,
Oldread, E.,
Livingston, D. M.,
 and Eckner, R.



(1995)

<I>Nature</I>
<B>374</B>,
81-84<!-- HIGHWIRE ID="275:52:40946:4" --><A HREF="/cgi/external_ref?access_num=7870178&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7870178&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Lundblad, J. R.,
Kwok, R. P.,
Laurance, M. E.,
Harter, M. L.,
 and Goodman, R. H.



(1995)

<I>Nature</I>
<B>374</B>,
85-88<!-- HIGHWIRE ID="275:52:40946:5" --><A HREF="/cgi/external_ref?access_num=7870179&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7870179&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Akimaru, H.,
Chen, Y.,
Dai, P.,
Hou, D. X.,
Nonaka, M.,
Smolik, S. M.,
Armstrong, S.,
Goodman, R. H.,
 and Ishii, S.



(1997)

<I>Nature</I>
<B>386</B>,
735-738<!-- HIGHWIRE ID="275:52:40946:6" --><A HREF="/cgi/external_ref?access_num=10.1038/41937&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9109493&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9109493&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Li, Q.,
Herrler, M.,
Landsberger, N.,
Kaludov, N.,
Ogryzko, V. V.,
Nakatani, Y.,
 and Wolffe, A. P.



(1998)

<I>EMBO J.</I>
<B>17</B>,
6300-6315<!-- HIGHWIRE ID="275:52:40946:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=17/21/6300"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Wilson, R.,
Ainscough, R.,
Anderson, K.,
Baynes, C.,
Berks, M.,
Bonfield, J.,
Burton, J.,
Connell, M.,
Copsey, T.,
Cooper, J.,
<I>et al.</I>.



(1994)

<I>Nature</I>
<B>368</B>,
32-38<!-- HIGHWIRE ID="275:52:40946:8" --><A HREF="/cgi/external_ref?access_num=7906398&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7906398&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Shikama, N.,
Lyon, J.,
 and La Thangue, N. B.



(1997)

<I>Trends Cell Biol.</I>
<B>7</B>,
230-236<!-- HIGHWIRE ID="275:52:40946:9" --><A HREF="/cgi/external_ref?access_num=10.1016/S0962-8924(97)01048-9&link_type=DOI">[CrossRef]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Giles, R. H.,
Peters, D. J.,
 and Breuning, M. H.



(1998)

<I>Trends Genet.</I>
<B>14</B>,
178-183<!-- HIGHWIRE ID="275:52:40946:10" --><A HREF="/cgi/external_ref?access_num=10.1016/S0168-9525(98)01438-3&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9613201&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9613201&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Kwok, R. P.,
Lundblad, J. R.,
Chrivia, J. C.,
Richards, J. P.,
Bachinger, H. P.,
Brennan, R. G.,
Roberts, S. G.,
Green, M. R.,
 and Goodman, R. H.



(1994)

<I>Nature</I>
<B>370</B>,
223-226<!-- HIGHWIRE ID="275:52:40946:11" --><A HREF="/cgi/external_ref?access_num=7913207&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7913207&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Janknecht, R.,
 and Hunter, T.



(1996)

<I>Curr. Biol.</I>
<B>6</B>,
951-954<!-- HIGHWIRE ID="275:52:40946:12" --><A HREF="/cgi/external_ref?access_num=8805328&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8805328&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Abraham, S. E.,
Lobo, S.,
Yaciuk, P.,
Wang, H. G.,
 and Moran, E.



(1993)

<I>Oncogene</I>
<B>8</B>,
1639-1647<!-- HIGHWIRE ID="275:52:40946:13" --><A HREF="/cgi/external_ref?access_num=8502484&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8502484&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Nakajima, T.,
Uchida, C.,
Anderson, S. F.,
Parvin, J. D.,
 and Montminy, M.



(1997)

<I>Genes Dev.</I>
<B>11</B>,
738-747<!-- HIGHWIRE ID="275:52:40946:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=11/6/738">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Yuan, W.,
Condorelli, G.,
Caruso, M.,
Felsani, A.,
 and Giordano, A.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
9009-9013<!-- HIGHWIRE ID="275:52:40946:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/15/9009"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Ogryzko, V. V.,
Schiltz, R. L.,
Russanova, V.,
Howard, B. H.,
 and Nakatani, Y.



(1996)

<I>Cell</I>
<B>87</B>,
953-959<!-- HIGHWIRE ID="275:52:40946:16" --><A HREF="/cgi/external_ref?access_num=8945521&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8945521&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Bannister, A. J.,
 and Kouzarides, T.



(1996)

<I>Nature</I>
<B>384</B>,
641-643<!-- HIGHWIRE ID="275:52:40946:17" --><A HREF="/cgi/external_ref?access_num=8967953&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8967953&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Gu, W.,
 and Roeder, R. G.



(1997)

<I>Cell</I>
<B>90</B>,
595-606<!-- HIGHWIRE ID="275:52:40946:18" --><A HREF="/cgi/external_ref?access_num=9288740&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9288740&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Kraus, W. L.,
 and Kadonaga, J. T.



(1998)

<I>Genes Dev.</I>
<B>12</B>,
331-342<!-- HIGHWIRE ID="275:52:40946:19" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=12/3/331"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Naar, A. M.,
Beaurang, P. A.,
Robinson, K. M.,
Oliner, J. D.,
Avizonis, D.,
Scheek, S.,
Zwicker, J.,
Kadonaga, J. T.,
 and Tjian, R.



(1998)

<I>Genes Dev.</I>
<B>12</B>,
3020-3031<!-- HIGHWIRE ID="275:52:40946:20" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=12/19/3020"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Zhang, W.,
 and Bieker, J. J.



(1998)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>95</B>,
9855-9860<!-- HIGHWIRE ID="275:52:40946:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=95/17/9855"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Boyes, J.,
Byfield, P.,
Nakatani, Y.,
 and Ogryzko, V.



(1998)

<I>Nature</I>
<B>396</B>,
594-598<!-- HIGHWIRE ID="275:52:40946:22" --><A HREF="/cgi/external_ref?access_num=10.1038/25166&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9859997&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9859997&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Imhof, A.,
Yang, X. J.,
Ogryzko, V. V.,
Nakatani, Y.,
Wolffe, A. P.,
 and Ge, H.



(1997)

<I>Curr. Biol.</I>
<B>7</B>,
689-692<!-- HIGHWIRE ID="275:52:40946:23" --><A HREF="/cgi/external_ref?access_num=9285713&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9285713&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Chakravarti, D.,
Ogryzko, V.,
Kao, H. Y.,
Nash, A.,
Chen, H.,
Nakatani, Y.,
 and Evans, R. M.



(1999)

<I>Cell</I>
<B>96</B>,
393-403<!-- HIGHWIRE ID="275:52:40946:24" --><A HREF="/cgi/external_ref?access_num=10025405&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10025405&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Hamamori, Y.,
Sartorelli, V.,
Ogryzko, V.,
Puri, P. L.,
Wu, H. Y.,
Wang, J. Y.,
Nakatani, Y.,
 and Kedes, L.



(1999)

<I>Cell</I>
<B>96</B>,
405-413<!-- HIGHWIRE ID="275:52:40946:25" --><A HREF="/cgi/external_ref?access_num=10025406&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10025406&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Giordano, A.,
 and Avantaggiati, M. L.



(1999)

<I>J. Cell. Physiol.</I>
<B>181</B>,
218-230<!-- HIGHWIRE ID="275:52:40946:26" --><A HREF="/cgi/external_ref?access_num=10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.3.CO;2-X&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10497301&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10497301&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Avantaggiati, M. L.,
Carbone, M.,
Graessmann, A.,
Nakatani, Y.,
Howard, B.,
 and Levine, A. S.



(1996)

<I>EMBO J.</I>
<B>15</B>,
2236-2248<!-- HIGHWIRE ID="275:52:40946:27" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=15/9/2236">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Nakajima, T.,
Fukamizu, A.,
Takahashi, J.,
Gage, F. H.,
Fisher, T.,
Blenis, J.,
 and Montminy, M. R.



(1996)

<I>Cell</I>
<B>86</B>,
465-474<!-- HIGHWIRE ID="275:52:40946:28" --><A HREF="/cgi/external_ref?access_num=8756728&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8756728&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Yaciuk, P.,
 and Moran, E.



(1991)

<I>Mol. Cell. Biol.</I>
<B>11</B>,
5389-5397<!-- HIGHWIRE ID="275:52:40946:29" --><A HREF="/cgi/external_ref?access_num=1833633&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1833633&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Xu, L.,
Lavinsky, R. M.,
Dasen, J. S.,
Flynn, S. E.,
McInerney, E. M.,
Mullen, T. M.,
Heinzel, T.,
Szeto, D.,
Korzus, E.,
Kurokawa, R.,
Aggarwal, A. K.,
Rose, D. W.,
Glass, C. K.,
 and Rosenfeld, M. G.



(1998)

<I>Nature</I>
<B>395</B>,
301-306<!-- HIGHWIRE ID="275:52:40946:30" --><A HREF="/cgi/external_ref?access_num=10.1038/26270&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9751061&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9751061&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Chawla, S.,
Hardingham, G. E.,
Quinn, D. R.,
 and Bading, H.



(1998)

<I>Science</I>
<B>281</B>,
1505-1509<!-- HIGHWIRE ID="275:52:40946:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=281/5382/1505"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Ait-Si-Ali, S.,
Ramirez, S.,
Barre, F. X.,
Dkhissi, F.,
Magnaghi-Jaulin, L.,
Girault, J. A.,
Robin, P.,
Knibiehler, M.,
Pritchard, L. L.,
Ducommun, B.,
Trouche, D.,
 and Harel-Bellan, A.



(1998)

<I>Nature</I>
<B>396</B>,
184-186<!-- HIGHWIRE ID="275:52:40946:32" --><A HREF="/cgi/external_ref?access_num=10.1038/24190&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9823900&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9823900&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Hu, S. C.,
Chrivia, J.,
 and Ghosh, A.



(1999)

<I>Neuron</I>
<B>22</B>,
799-808<!-- HIGHWIRE ID="275:52:40946:33" --><A HREF="/cgi/external_ref?access_num=10.1016/S0896-6273(01)80037-4&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10230799&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10230799&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Dignam, J. D.,
Lebovitz, R. M.,
 and Roeder, R. G.



(1983)

<I>Nucleic Acids Res.</I>
<B>11</B>,
1475-1489<!-- HIGHWIRE ID="275:52:40946:34" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nar&resid=11/5/1475">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Johnson, J. E.,
Edwards, A. S.,
 and Newton, A. C.



(1997)

<I>J. Biol. Chem.</I>
<B>272</B>,
30787-30792<!-- HIGHWIRE ID="275:52:40946:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=272/49/30787"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Uberall, F.,
Giselbrecht, S.,
Hellbert, K.,
Fresser, F.,
Bauer, B.,
Gschwendt, M.,
Grunicke, H. H.,
 and Baier, G.



(1997)

<I>J. Biol. Chem.</I>
<B>272</B>,
4072-4078<!-- HIGHWIRE ID="275:52:40946:36" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=272/7/4072"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

Fernandez, J.,
Andrews, L.,
 and Mische, S. M.



(1994)

<I>Anal Biochem</I>
<B>218</B>,
112-117<!-- HIGHWIRE ID="275:52:40946:37" --><A HREF="/cgi/external_ref?access_num=10.1006/abio.1994.1148&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8053543&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8053543&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B38">38.</a>
    <TD VALIGN=TOP>

Luo, K. X.,
Hurley, T. R.,
 and Sefton, B. M.



(1991)

<I>Methods Enzymol.</I>
<B>201</B>,
149-152<!-- HIGHWIRE ID="275:52:40946:38" --><A HREF="/cgi/external_ref?access_num=1943761&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1943761&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B39">39.</a>
    <TD VALIGN=TOP>

Sullivan, S.,
 and Wong, T. W.



(1991)

<I>Anal. Biochem.</I>
<B>197</B>,
65-68<!-- HIGHWIRE ID="275:52:40946:39" --><A HREF="/cgi/external_ref?access_num=1952076&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1952076&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B40">40.</a>
    <TD VALIGN=TOP>

Berry, M.,
Metzger, D.,
 and Chambon, P.



(1990)

<I>EMBO J.</I>
<B>9</B>,
2811-2818<!-- HIGHWIRE ID="275:52:40946:40" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=9/9/2811">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B41">41.</a>
    <TD VALIGN=TOP>Deleted in proof
    <!-- HIGHWIRE ID="275:52:40946:41" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B42">42.</a>
    <TD VALIGN=TOP>Deleted in proof
    <!-- HIGHWIRE ID="275:52:40946:42" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B43">43.</a>
    <TD VALIGN=TOP>Deleted in proof
    <!-- HIGHWIRE ID="275:52:40946:43" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B44">44.</a>
    <TD VALIGN=TOP>Deleted in proof
    <!-- HIGHWIRE ID="275:52:40946:44" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B45">45.</a>
    <TD VALIGN=TOP>

Pearson, R. B.,
 and Kemp, B. E.



(1991)

<I>Methods Enzymol.</I>
<B>200</B>,
62-81<!-- HIGHWIRE ID="275:52:40946:45" --><A HREF="/cgi/external_ref?access_num=1956339&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1956339&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B46">46.</a>
    <TD VALIGN=TOP>

Hofmann, J.



(1997)

<I>FASEB J.</I>
<B>11</B>,
649-669<!-- HIGHWIRE ID="275:52:40946:46" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=fasebj&resid=11/8/649">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B47">47.</a>
    <TD VALIGN=TOP>

Xu, J.,
 and Clark, R. A.



(1997)

<I>J. Cell Biol.</I>
<B>136</B>,
473-483<!-- HIGHWIRE ID="275:52:40946:47" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jcb&resid=136/2/473"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B48">48.</a>
    <TD VALIGN=TOP>

Kobayashi, E.,
Nakano, H.,
Morimoto, M.,
 and Tamaoki, T.



(1989)

<I>Biochem. Biophys. Res. Commun.</I>
<B>159</B>,
548-553<!-- HIGHWIRE ID="275:52:40946:48" --><A HREF="/cgi/external_ref?access_num=2467670&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2467670&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B49">49.</a>
    <TD VALIGN=TOP>

Newton, A. C.



(1997)

<I>Curr. Opin. Cell Biol.</I>
<B>9</B>,
161-167<!-- HIGHWIRE ID="275:52:40946:49" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(97)80058-0&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9069266&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9069266&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B50">50.</a>
    <TD VALIGN=TOP>

Lee, J. S.,
See, R. H.,
Deng, T.,
 and Shi, Y.



(1996)

<I>Mol. Cell. Biol.</I>
<B>16</B>,
4312-4326<!-- HIGHWIRE ID="275:52:40946:50" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=16/8/4312">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B51">51.</a>
    <TD VALIGN=TOP>

Moran, E.



(1993)

<I>Curr. Opin. Genet. Dev.</I>
<B>3</B>,
63-70<!-- HIGHWIRE ID="275:52:40946:51" --><A HREF="/cgi/external_ref?access_num=8453277&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8453277&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B52">52.</a>
    <TD VALIGN=TOP>

Kung, A. L.,
Rebel, V. I.,
Bronson, R. T.,
Ch'ng, L. E.,
Sieff, C. A.,
Livingston, D. M.,
 and Yao, T. P.



(2000)

<I>Genes Dev.</I>
<B>14</B>,
272-277<!-- HIGHWIRE ID="275:52:40946:52" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=14/3/272"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B53">53.</a>
    <TD VALIGN=TOP>

Muraoka, M.,
Konishi, M.,
Kikuchi-Yanoshita, R.,
Tanaka, K.,
Shitara, N.,
Chong, J. M.,
Iwama, T.,
 and Miyaki, M.



(1996)

<I>Oncogene</I>
<B>12</B>,
1565-1569<!-- HIGHWIRE ID="275:52:40946:53" --><A HREF="/cgi/external_ref?access_num=8622873&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8622873&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B54">54.</a>
    <TD VALIGN=TOP>

Yao, T. P.,
Oh, S. P.,
Fuchs, M.,
Zhou, N. D.,
Ch'ng, L. E.,
Newsome, D.,
Bronson, R. T.,
Li, E.,
Livingston, D. M.,
 and Eckner, R.



(1998)

<I>Cell</I>
<B>93</B>,
361-372<!-- HIGHWIRE ID="275:52:40946:54" --><A HREF="/cgi/external_ref?access_num=9590171&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9590171&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B55">55.</a>
    <TD VALIGN=TOP>

Kawasaki, H.,
Eckner, R.,
Yao, T. P.,
Taira, K.,
Chiu, R.,
Livingston, D. M.,
 and Yokoyama, K. K.



(1998)

<I>Nature</I>
<B>393</B>,
284-289<!-- HIGHWIRE ID="275:52:40946:55" --><A HREF="/cgi/external_ref?access_num=10.1038/30538&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9607768&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9607768&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B56">56.</a>
    <TD VALIGN=TOP>

Asaoka, Y.,
Nakamura, S.,
Yoshida, K.,
 and Nishizuka, Y.



(1992)

<I>Trends Biochem. Sci.</I>
<B>17</B>,
414-417<!-- HIGHWIRE ID="275:52:40946:56" --><A HREF="/cgi/external_ref?access_num=1455509&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1455509&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B57">57.</a>
    <TD VALIGN=TOP>

Jaken, S.



(1996)

<I>Curr. Opin. Cell Biol.</I>
<B>8</B>,
168-173<!-- HIGHWIRE ID="275:52:40946:57" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(96)80062-7&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8791416&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8791416&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B58">58.</a>
    <TD VALIGN=TOP>

Mischak, H.,
Pierce, J. H.,
Goodnight, J.,
Kazanietz, M. G.,
Blumberg, P. M.,
 and Mushinski, J. F.



(1993)

<I>J. Biol. Chem.</I>
<B>268</B>,
20110-20115<!-- HIGHWIRE ID="275:52:40946:58" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=268/27/20110"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. M. Coleman, M. Dutertre, A. El-Gharbawy, B. G. Rowan, N. L. Weigel, and C. L. Smith<BR>
	<STRONG>Mechanistic Differences in the Activation of Estrogen Receptor-alpha  (ERalpha )- and ERbeta -dependent Gene Expression by cAMP Signaling Pathway(s)</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        April&nbsp;11,&nbsp;2003;
	278(15):
	12834 - 12845.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/15/12834">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/15/12834">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/15/12834">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	E. E. Corcoran, J. D. Joseph, J. A. MacDonald, C. D. Kane, T. A. J. Haystead, and A. R. Means<BR>
	<STRONG>Proteomic Analysis of Calcium/Calmodulin-dependent Protein Kinase I and IV in Vitro Substrates Reveals Distinct Catalytic Preferences</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;21,&nbsp;2003;
	278(12):
	10516 - 10522.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/12/10516">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/12/10516">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/12/10516">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jneurochem.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurochem.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jneurochem.org"><IMG ALT="J Neurochem" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jneurochem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Yalcin, E. Koulich, S. Mohamed, L. Liu, and S. R. D'Mello<BR>
	<STRONG>Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB-binding protein and NF-{kappa}B</STRONG><BR>
	
		
			J. Neurochem.,
		
	
        
        January&nbsp;15,&nbsp;2003;
	84(2):
	397 - 408.
<BR>
<A HREF="http://www.jneurochem.org/cgi/content/abstract/84/2/397">[Abstract]</A>

<A HREF="http://www.jneurochem.org/cgi/content/full/84/2/397">[Full Text]</A>
<A HREF="http://www.jneurochem.org/cgi/reprint/84/2/397">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboreports.npgjournals.com"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboreports.npgjournals.com/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboreports.npgjournals.com"><IMG ALT="EMBO Reports" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emborep.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Rudenko, D. Bennett, and L. Alphey<BR>
	<STRONG>Trithorax interacts with type 1 serine/threonine protein phosphatase in Drosophila</STRONG><BR>
	
		
			EMBO Rep.,
		
	
        
        January&nbsp;1,&nbsp;2003;
	4(1):
	59 - 63.
<BR>
<A HREF="http://emboreports.npgjournals.com/cgi/content/abstract/4/1/59">[Abstract]</A>

<A HREF="http://emboreports.npgjournals.com/cgi/content/full/4/1/59">[Full Text]</A>
<A HREF="http://emboreports.npgjournals.com/cgi/reprint/4/1/59">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. Misra, E. D. Owuor, W. Li, S. Yu, C. Qi, K. Meyer, Y.-J. Zhu, M. S. Rao, A.-N. T. Kong, and J. K. Reddy<BR>
	<STRONG>Phosphorylation of Transcriptional Coactivator Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein (PBP). STIMULATION OF TRANSCRIPTIONAL REGULATION BY MITOGEN-ACTIVATED PROTEIN KINASE</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December&nbsp;13,&nbsp;2002;
	277(50):
	48745 - 48754.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/50/48745">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/50/48745">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/50/48745">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. Boskovic, D. Desai, and R. M. Niles<BR>
	<STRONG>Regulation of Retinoic Acid Receptor alpha  by Protein Kinase C in B16 Mouse Melanoma Cells</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        July&nbsp;19,&nbsp;2002;
	277(29):
	26113 - 26119.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/29/26113">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/29/26113">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/29/26113">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://mcb.asm.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mcb.asm.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://mcb.asm.org"><IMG ALT="Mol. Cell. Biol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/mcb.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. D. Mehta, A. Radominska-Pandya, G. S. Kapoor, B. Dave, and B. A. Atkins<BR>
	<STRONG>Critical Role of Diacylglycerol- and Phospholipid-Regulated Protein Kinase C{varepsilon} in Induction of Low-Density Lipoprotein Receptor Transcription in Response to Depletion of Cholesterol</STRONG><BR>
	
		
			Mol. Cell. Biol.,
		
	
        
        June&nbsp;1,&nbsp;2002;
	22(11):
	3783 - 3793.
<BR>
<A HREF="http://mcb.asm.org/cgi/content/abstract/22/11/3783">[Abstract]</A>

<A HREF="http://mcb.asm.org/cgi/content/full/22/11/3783">[Full Text]</A>
<A HREF="http://mcb.asm.org/cgi/reprint/22/11/3783">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.ebmonline.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.ebmonline.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.ebmonline.org"><IMG ALT="Exp Biol Med" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/psebm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. K. Ghosh<BR>
	<STRONG>Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis</STRONG><BR>
	
		
			Experimental Biology and Medicine,
		
	
        
        May&nbsp;1,&nbsp;2002;
	227(5):
	301 - 314.
<BR>
<A HREF="http://www.ebmonline.org/cgi/content/abstract/227/5/301">[Abstract]</A>

<A HREF="http://www.ebmonline.org/cgi/content/full/227/5/301">[Full Text]</A>
<A HREF="http://www.ebmonline.org/cgi/reprint/227/5/301">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Kawabata, K.-i. Kawahara, T. Kanekura, N. Araya, H. Daitoku, M. Hatta, N. Miura, A. Fukamizu, T. Kanzaki, I. Maruyama, and T. Nakajima<BR>
	<STRONG>Possible Role of Transcriptional Coactivator P/CAF and Nuclear Acetylation in Calcium-induced Keratinocyte Differentiation</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;8,&nbsp;2002;
	277(10):
	8099 - 8105.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/10/8099">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/10/8099">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/10/8099">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. Gusterson, B. Brar, D. Faulkes, A. Giordano, J. Chrivia, and D. Latchman<BR>
	<STRONG>The Transcriptional Co-activators CBP and p300 Are Activated via Phenylephrine through the p42/p44 MAPK Cascade</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;25,&nbsp;2002;
	277(4):
	2517 - 2524.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/4/2517">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/4/2517">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/4/2517">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://mcb.asm.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://mcb.asm.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://mcb.asm.org"><IMG ALT="Mol. Cell. Biol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/mcb.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Ko, G. R. Cardona, A. Henrion-Caude, and W. W. Chin<BR>
	<STRONG>Identification and Characterization of a Tissue-Specific Coactivator, GT198, That Interacts with the DNA-Binding Domains of Nuclear Receptors</STRONG><BR>
	
		
			Mol. Cell. Biol.,
		
	
        
        January&nbsp;1,&nbsp;2002;
	22(1):
	357 - 369.
<BR>
<A HREF="http://mcb.asm.org/cgi/content/abstract/22/1/357">[Abstract]</A>

<A HREF="http://mcb.asm.org/cgi/content/full/22/1/357">[Full Text]</A>
<A HREF="http://mcb.asm.org/cgi/reprint/22/1/357">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	W. Yang, Y. H. Hong, X.-Q. Shen, C. Frankowski, H. S. Camp, and T. Leff<BR>
	<STRONG>Regulation of Transcription by AMP-activated Protein Kinase. PHOSPHORYLATION OF p300 BLOCKS ITS INTERACTION WITH NUCLEAR RECEPTORS</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;19,&nbsp;2001;
	276(42):
	38341 - 38344.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/42/38341">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/42/38341">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/42/38341">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	E. De Fabiani, N. Mitro, A. C. Anzulovich, A. Pinelli, G. Galli, and M. Crestani<BR>
	<STRONG>The Negative Effects of Bile Acids and Tumor Necrosis Factor-alpha  on the Transcription of Cholesterol 7alpha -Hydroxylase Gene (CYP7A1) Converge to Hepatic Nuclear Factor-4. A NOVEL MECHANISM OF FEEDBACK REGULATION OF BILE ACID SYNTHESIS MEDIATED BY NUCLEAR RECEPTORS</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        August&nbsp;17,&nbsp;2001;
	276(33):
	30708 - 30716.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/33/30708">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/33/30708">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/33/30708">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/52/40946">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/52/40946">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/52/40946">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/52/40946&title=Phosphorylation+of+p300+at+Serine+89+by+Protein+Kinase+C">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007832200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=11020388&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=11020388&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Yuan+LW&link_type=AUTHORSEARCH">Yuan, L. W.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Gambee+JE&link_type=AUTHORSEARCH">Gambee, J. E.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/52/40946&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F52%2F40946"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/52/40946">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/52/40946<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007832200v1">M007832200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue52/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2000 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
